BibTex RIS Cite

Paraneoplastik sendromlar

Year 2001, Volume: 7 Issue: 1-2, 156 - 159, 01.06.2001

Abstract

Bu makalede paraneoplastik sendromların tanımı, çeşitleri, semptomları ve sağaltım ilkeleri kısaca değerlendirilmiştir

References

  • 1. Dobson JM. Gorman NT: Paraneoplastic syndromes. “R A S White (ed): Manııal of Smal Animal Oncology”, p81, BSAVA, (1991).
  • 2. Ogilvie GK: Paraneoplastic syndromes. "S J Ettinger, E C Feldam (ed): Textbook of Veterinary Internal Medicine” p513, WB Saunders Co, Philadelphia, (1995).
  • 3. Ogilvie GK: Paraneoplastic syndromes. “S J Witrow, E G McEwen (ed): Clinical Veterinary Oncology” p29, JB Lippincott, Philadelphia, (1989).
  • 4. Meuten DJ: Hypercalcemia, Vet Clin North Am 14:891(1984).
  • 5. Kruger JM, Osborne CA, Polzin DJ: Treatment of hypercalcemia. “R W Kirk (ed): Current Veterinary Therapy IX" p75, WB Saunders Co, Philadelphia. (1986).
  • 6. Lowitz BB: Paraneoplastic syndromes. “C M Haskell (ed): Cancer Treatment” p841, 3 Ü1 Ed, WB Saunders Co, Philadelphia, (1990).
  • 7. Leifer CE, Peterson ME: Hypoglycemia. Vet Clin North Am 14: 873,(1984).
  • 8. Meyer DJ, Coles EH, Rich LJ: Veterinary Laboratory Medicine. Interpretation and Diagnosis, p 12, WB Saunders Co, Philadelphia, (1992).
  • 9. Ogilvie GK, Vail DM: Unique metabolic alterations associated with cancer cachexia in dog. “RW Kirk (ed): Current Veterinary Therapy XI” p433, WB Saunders Co, Philadelphia, (1992).
  • 10. Ogilvie GK, Ford RD, Vail DM: Alterations in lipoprotein profiles in dogs with lymphoma, J Vet Intern Med 4: 8, (1994).
  • 11. Ogilvie GK: Metabolic alterations and nutritional therapy for the veterinary cancer patient, Comp Contin Ed 15: 925-936, (1993).
  • 12. Giger U, Gorman NT: Acute complications of cancer therapy. “N T Gorman (ed): Oncology” pl47, Chuıchill Livingstone, New York, (1986).
  • 13. Ogilvie GK. Haschek WA, McKierman B, Withıow SJ, Richaıdson RC: Classification of primary lung tumors in dog: 210cases (1975- 1985), JAVMA 195; 106, (1989).
  • 14. Bilezikian JP: Management of acute hypercalcemia, N Engl J Med 18:1196, (1992).
  • 15. Chlebowski RT, Heber D: Metebolic abnormalities in cancer patients: caıbohydrate metabolism, Suıg Clin North Am 66: 957, (1986).
  • 16. Weir EC, Nordin RW, Matus RE: Humoral hypercalcemia of malignancy in canine lymphosarcoma. Endocrinology 122 :602, (1988).
  • 17. Leifer CE, Peteıson ME, Matus RE, Patnaik AK: Hypoglycemia associated with non-isle-cell tumors in 13 dogs, JAVMA 186:53,(1985).
  • 18. Ogilvie GK, Felsberg PJ. Harris SW: Short term effect of cyclophosphamide and azathioprine on the selected aspects of the canine immune system, J Vet Immunol Iınmunopathol 18: 119,(1988).
  • 19. Ogilvie GK, Walters LM, Fettman MJ: Energy expenditure in dogs with lymphoma fed two specialized diets, Cancer 71:31- 46,(1993).
  • 20. Krishnaswamy K: Effects of malnutrion on drug metabolism and toxicity in humans, Nurt Toxicol 2:105, (1987).

Paraneoplastic syndromes

Year 2001, Volume: 7 Issue: 1-2, 156 - 159, 01.06.2001

Abstract

In this article, the definition, variety, symptoms, and treatment principles of paraneoplastic syndrome were reviewed

References

  • 1. Dobson JM. Gorman NT: Paraneoplastic syndromes. “R A S White (ed): Manııal of Smal Animal Oncology”, p81, BSAVA, (1991).
  • 2. Ogilvie GK: Paraneoplastic syndromes. "S J Ettinger, E C Feldam (ed): Textbook of Veterinary Internal Medicine” p513, WB Saunders Co, Philadelphia, (1995).
  • 3. Ogilvie GK: Paraneoplastic syndromes. “S J Witrow, E G McEwen (ed): Clinical Veterinary Oncology” p29, JB Lippincott, Philadelphia, (1989).
  • 4. Meuten DJ: Hypercalcemia, Vet Clin North Am 14:891(1984).
  • 5. Kruger JM, Osborne CA, Polzin DJ: Treatment of hypercalcemia. “R W Kirk (ed): Current Veterinary Therapy IX" p75, WB Saunders Co, Philadelphia. (1986).
  • 6. Lowitz BB: Paraneoplastic syndromes. “C M Haskell (ed): Cancer Treatment” p841, 3 Ü1 Ed, WB Saunders Co, Philadelphia, (1990).
  • 7. Leifer CE, Peterson ME: Hypoglycemia. Vet Clin North Am 14: 873,(1984).
  • 8. Meyer DJ, Coles EH, Rich LJ: Veterinary Laboratory Medicine. Interpretation and Diagnosis, p 12, WB Saunders Co, Philadelphia, (1992).
  • 9. Ogilvie GK, Vail DM: Unique metabolic alterations associated with cancer cachexia in dog. “RW Kirk (ed): Current Veterinary Therapy XI” p433, WB Saunders Co, Philadelphia, (1992).
  • 10. Ogilvie GK, Ford RD, Vail DM: Alterations in lipoprotein profiles in dogs with lymphoma, J Vet Intern Med 4: 8, (1994).
  • 11. Ogilvie GK: Metabolic alterations and nutritional therapy for the veterinary cancer patient, Comp Contin Ed 15: 925-936, (1993).
  • 12. Giger U, Gorman NT: Acute complications of cancer therapy. “N T Gorman (ed): Oncology” pl47, Chuıchill Livingstone, New York, (1986).
  • 13. Ogilvie GK. Haschek WA, McKierman B, Withıow SJ, Richaıdson RC: Classification of primary lung tumors in dog: 210cases (1975- 1985), JAVMA 195; 106, (1989).
  • 14. Bilezikian JP: Management of acute hypercalcemia, N Engl J Med 18:1196, (1992).
  • 15. Chlebowski RT, Heber D: Metebolic abnormalities in cancer patients: caıbohydrate metabolism, Suıg Clin North Am 66: 957, (1986).
  • 16. Weir EC, Nordin RW, Matus RE: Humoral hypercalcemia of malignancy in canine lymphosarcoma. Endocrinology 122 :602, (1988).
  • 17. Leifer CE, Peteıson ME, Matus RE, Patnaik AK: Hypoglycemia associated with non-isle-cell tumors in 13 dogs, JAVMA 186:53,(1985).
  • 18. Ogilvie GK, Felsberg PJ. Harris SW: Short term effect of cyclophosphamide and azathioprine on the selected aspects of the canine immune system, J Vet Immunol Iınmunopathol 18: 119,(1988).
  • 19. Ogilvie GK, Walters LM, Fettman MJ: Energy expenditure in dogs with lymphoma fed two specialized diets, Cancer 71:31- 46,(1993).
  • 20. Krishnaswamy K: Effects of malnutrion on drug metabolism and toxicity in humans, Nurt Toxicol 2:105, (1987).
There are 20 citations in total.

Details

Primary Language Turkish
Journal Section Research Article
Authors

İsmail Alkan This is me

Loğman Aslan This is me

Publication Date June 1, 2001
Published in Issue Year 2001 Volume: 7 Issue: 1-2

Cite

APA Alkan, İ., & Aslan, L. (2001). Paraneoplastik sendromlar. Yüzüncü Yıl Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, 7(1-2), 156-159.
AMA Alkan İ, Aslan L. Paraneoplastik sendromlar. Yüzüncü Yıl Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi. June 2001;7(1-2):156-159.
Chicago Alkan, İsmail, and Loğman Aslan. “Paraneoplastik Sendromlar”. Yüzüncü Yıl Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 7, no. 1-2 (June 2001): 156-59.
EndNote Alkan İ, Aslan L (June 1, 2001) Paraneoplastik sendromlar. Yüzüncü Yıl Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 7 1-2 156–159.
IEEE İ. Alkan and L. Aslan, “Paraneoplastik sendromlar”, Yüzüncü Yıl Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, vol. 7, no. 1-2, pp. 156–159, 2001.
ISNAD Alkan, İsmail - Aslan, Loğman. “Paraneoplastik Sendromlar”. Yüzüncü Yıl Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi 7/1-2 (June 2001), 156-159.
JAMA Alkan İ, Aslan L. Paraneoplastik sendromlar. Yüzüncü Yıl Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi. 2001;7:156–159.
MLA Alkan, İsmail and Loğman Aslan. “Paraneoplastik Sendromlar”. Yüzüncü Yıl Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, vol. 7, no. 1-2, 2001, pp. 156-9.
Vancouver Alkan İ, Aslan L. Paraneoplastik sendromlar. Yüzüncü Yıl Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi. 2001;7(1-2):156-9.